Works by Wu, Yaohui


Results: 25
    1
    2
    4
    5
    6

    Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 10, p. 1113, doi. 10.1002/ajh.25582
    By:
    • Jiang, Huiwen;
    • Li, Chenggong;
    • Yin, Ping;
    • Guo, Tao;
    • Liu, Lin;
    • Xia, Linghui;
    • Wu, Yaohui;
    • Zhou, Fen;
    • Ai, Lisha;
    • Shi, Wei;
    • Lu, Xuan;
    • Wang, Huafang;
    • Tang, Lu;
    • Wei, Qiuzhe;
    • Deng, Jun;
    • Jin, Runming;
    • Xiong, Wei;
    • Dong, Jian;
    • Mei, Heng;
    • Hu, Yu
    Publication type:
    Article
    7
    8
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25